Home > Healthcare > Medical Services > Lab Services > Central Lab Market
Central Lab Market size was valued at around USD 3.1 billion in 2023 and is expected to reach around USD 5.1 billion by 2032 at a CAGR of 5.8% during the forecast period. The growing emphasis on outsourcing of testing services coupled with extensive growth in research and development investments are driving the market growth.
Outsourcing testing services is increasingly driving the growth of the central lab market, as organizations seek cost efficiency, high-quality outcomes, and specialized testing capabilities. The U.S. Food and Drug Administration (FDA) reported a 25% increase in clinical trials utilizing outsourced central laboratory services in 2022 compared to 2019, highlighting the growing reliance on these specialized labs for critical testing. This trend allows organizations to focus on their core activities while central labs provide precise and efficient testing, thereby accelerating market expansion.
A central lab is a dedicated facility or group of laboratories that provides comprehensive laboratory testing services for clinical trials, pharmaceutical research, and various diagnostic purposes. These labs are equipped with advanced technologies and staffed by skilled professionals to conduct a wide range of tests and analyses on biological samples, including blood, urine, tissue, and other specimens.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Central Lab Market Size in 2023: | USD 3.1 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 5.8% |
2024 – 2032 Value Projection: | USD 5.1 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 110 |
Tables, Charts & Figures: | 121 |
Segments covered: | Services, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|